View Older Stories View More Recent Stories

Jul 7, 2021 07:00AM PureTech Announces Clinical Trial and Supply Agreement with BeiGene to Evaluate LYT-200 and Tislelizumab in Patients with Difficult-to-Treat Solid Tumors
Jun 30, 2021 07:00AM PureTech Founded Entity Vedanta Biosciences Announces New Data from Phase 1 Study of VE202 for the Treatment of Inflammatory Bowel Disease
Jun 23, 2021 08:46AM PureTech Founded Entity Karuna Therapeutics Announces Results from Phase 1b Trial Evaluating the Safety and Tolerability of KarXT in Healthy Elderly Volunteers
Jun 16, 2021 07:01AM PureTech Health Plc (PRTC) Acquires Remaining Interest in Founded Entity Alivio Therapeutics
Jun 16, 2021 07:00AM PureTech Acquires Remaining Interest in Founded Entity Alivio Therapeutics
May 27, 2021 01:32PM Results of Annual General Meeting
May 27, 2021 09:50AM PureTech Founded Entity Gelesis Presents Findings on Plenity®-Induced Weight Loss at the American Association of Clinical Endocrinology (AACE) 2021 Annual Virtual Meeting
May 26, 2021 08:15AM PureTech (PRTC) Founded Entity Akili Secures $160 Million in Financing
May 26, 2021 08:05AM PureTech Founded Entity Akili Secures $160 Million in Financing; Poised to Deliver on the Promise of Digital Therapeutics
May 25, 2021 07:00AM PureTech to Present at the Jefferies Virtual Healthcare Conference
May 12, 2021 07:00AM PureTech Forms Clinical Advisory Board for Idiopathic Pulmonary Fibrosis and Related Lung Disorders
Apr 28, 2021 11:13AM PureTech Announces Nature Publication Supporting Modulation of Meningeal Lymphatics to Target Alzheimer’s Disease Pathologies
Apr 26, 2021 08:28AM PureTech Health Plc (PRTC) Adds Jane Wildman to Board
Apr 26, 2021 08:05AM PureTech Founded Entity Gelesis Appoints Procter & Gamble Veteran Jane Wildman to Board of Directors
Apr 15, 2021 02:00AM PureTech Announces Annual Results for Year Ended December 31, 2020
Apr 12, 2021 07:19AM PureTech Health Plc (PRTC)
Apr 12, 2021 07:00AM PureTech Presents Promising Preclinical Data from LYT-210 Immuno-Oncology Program at American Association for Cancer Research (AACR) Annual Meeting
Apr 7, 2021 07:00AM PureTech to Present at Two Upcoming Investor Conferences
Apr 7, 2021 05:15AM PureTech Founded Entity Akili Collaborates with Weill Cornell Medicine, NewYork-Presbyterian Hospital and Vanderbilt University Medical Center to Study Digital Therapeutic AKL-T01 as Potential Treatme
Mar 26, 2021 08:08AM PureTech (PRTC) Founded Entity Akili Announces Results of EndeavorRx Clinical Study in Pediatric ADHD Published in Nature Digital Medicine
Mar 26, 2021 08:07AM PureTech Founded Entity Akili Announces the Results of EndeavorRx™ Clinical Study in Pediatric ADHD Published in Nature Digital Medicine
Mar 18, 2021 03:00AM PureTech Announces Board Member Retirement
Mar 15, 2021 03:00AM PureTech: Notice of Results
Mar 3, 2021 07:00AM PureTech to Present at The Barclays Global Healthcare Conference
Feb 25, 2021 09:17AM PureTech Announces Publication of Glyph™ Platform Preclinical Proof-of-Concept Study in Journal of Controlled Release
Feb 25, 2021 02:00AM PureTech Founded Entity Karuna Therapeutics Announces New England Journal of Medicine Publication of Data from EMERGENT-1 Phase 2 Trial Evaluating KarXT in Schizophrenia
Feb 18, 2021 07:00AM PureTech to Present at The SVB Leerink 10th Annual Global Healthcare Conference
Feb 10, 2021 06:25AM PureTech Health (PRTC) Receives Approximately $118 Million from Sale of Portion of Founded Entity Shares
Feb 10, 2021 02:00AM PureTech Founded Entity Vor Biopharma Closes Over $200M Initial Public Offering
Feb 10, 2021 02:00AM PureTech Receives Approximately $118 Million from Sale of Portion of Founded Entity Shares
Feb 8, 2021 07:00AM PureTech Founded Entity Vedanta Biosciences Appoints Mark Mullikin as Chief Financial Officer
Feb 5, 2021 06:50AM PureTech Founded Entity Vor Biopharma Announces Pricing of Initial Public Offering
Jan 29, 2021 02:00AM PureTech Adds Bharatt Chowrira, PureTech’s President and Chief of Business and Strategy, to Board of Directors
Jan 14, 2021 07:11AM PureTech Health Plc (PRTC) Founded Entity, Vor Biopharma, Announces FDA Clearance of IND Application for VOR33
Jan 14, 2021 07:05AM PureTech Founded Entity Vor Announces FDA Clearance of IND Application for VOR33
Jan 14, 2021 06:50AM PureTech Founded Entity Follica Adds Two Leaders in Aesthetic Medicine and Dermatology to its Board of Directors
Jan 12, 2021 06:52AM PureTech (PRTC) Founded Entity Vedanta Biosciences Announces $25 Million Investment from Pfizer Inc.
Jan 12, 2021 06:50AM PureTech Founded Entity Vedanta Biosciences Announces $25 Million Investment from Pfizer Inc.
Jan 5, 2021 08:18AM PureTech Health Plc (PRTC) Names George Farmer CFO
Jan 5, 2021 02:00AM PureTech Announces the Appointment of George Farmer, Ph.D., as Chief Financial Officer
Dec 21, 2020 07:00AM PureTech to Present at 38th Annual J.P. Morgan Healthcare Conference and Other Conferences
Dec 11, 2020 07:00AM PureTech Advances Wholly Owned Candidate LYT-200 into Phase 1 Trial for Potential Treatment of Metastatic Solid Tumors
Dec 10, 2020 07:36AM PureTech Health Plc (PRTC) Begins Phase 2a trial of LYT-100 (Deupirfenidone) in Lymphedema
Dec 10, 2020 07:00AM PureTech Initiates Phase 2a trial of LYT-100 (Deupirfenidone) in Lymphedema
Dec 9, 2020 07:00AM PureTech Founded Entity Follica Announces Pilot Study for Female Pattern Hair Loss Published in International Journal of Women’s Dermatology
Dec 3, 2020 07:00AM PureTech Initiates Phase 2 trial of LYT-100 (Deupirfenidone) in Long COVID Respiratory Complications and Related Sequelae
Nov 30, 2020 07:00AM PureTech to Host Virtual R&D Day for Investors on December 11, 2020
Nov 24, 2020 07:00AM PureTech Founded Entity Vedanta Biosciences Appoints Troy Ignelzi, Chief Financial Officer at Karuna Therapeutics, to its Board of Directors
Nov 18, 2020 06:07AM PureTech Health Plc (PRTC) Reports LYT-100 (Deupirfenidone) Demonstrates Tolerability and Pharmacokinetic Proof-of-Concept in Phase 1 Multiple Ascending Dose & Food Effect Study
Nov 18, 2020 02:00AM PureTech’s LYT-100 (Deupirfenidone) Demonstrates Tolerability and Pharmacokinetic Proof-of-Concept in Phase 1 Multiple Ascending Dose and Food Effect Study
View More Recent Stories View Older Stories